A new study published in the journal Cell Metabolism strongly suggests that low doses of weight loss drugs like Ozempic and Zepbound can counteract aging in middle-aged mice, adding to the growing suspicion that these medications might also increase human longevity. They also observed a control group of 10 young mice, three months old, and injected them with the saline solution for four weeks, while another nine young mice received exenatide. They then put all the mice, both young and older, through a battery of physical and cognitive tests to see the effects of aging and the difference that exenatide could make in their bodies. Meanwhile, younger mice that received exenatide didn’t seem to have much changes to their bodies. More on weight loss drugs: Huge Study Finds Constellation of Health Benefits for Ozempic Beyond Weight Loss